14-day Premium Trial Subscription Sign Up For FreeGet Free

$1.07 (4.90%)

Volume: 2M

Closed: Dec 07, 2021

Hollow Logo Score: -3.111

Athersys Stock Forecast

$1.07 (4.90%)

Volume: 2M

Closed: Dec 07, 2021

Score Hollow Logo -3.111

Athersys Stock Forecast NASDAQ:ATHX

Price Target and Analyst Ratings

Most Recent Rating

Needham & Company LLC is very positive about ATHX and gave it a "Buy" rating on Nov 10, 2020. The price target was set to $5.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-11-10 Buy Reiterated by Needham & Company LLC $1.94 $5.00
2020-10-12 Buy Reiterated by Dawson James $1.92
2020-08-11 Buy Reiterated by Needham & Company LLC $2.26 $5.00
2020-06-25 Buy Initiated by Bank of America $2.88 $5.00
2020-05-08 Buy Target Lowered by Needham & Company LLC $2.84 $6.00 → $5.00
2020-05-06 Buy Reiterated by Dawson James $2.55 $12.00
2020-04-23 Outperform Initiated by Smith Barney Citigroup $2.17 $14.00

ATHX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -27.49% during the next 3 months and, with a 90% probability hold a price between $0.67 and $0.89 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-12-09 $0.92 $1.07 $1.22
2021-12-10 $0.91 $1.06 $1.22
2021-12-13 $0.90 $1.05 $1.21
2021-12-14 $0.89 $1.05 $1.20
2021-12-15 $0.89 $1.04 $1.19
2021-12-16 $0.88 $1.03 $1.19
2021-12-17 $0.87 $1.02 $1.18
2021-12-20 $0.86 $1.02 $1.17
2021-12-21 $0.86 $1.01 $1.16
2021-12-22 $0.85 $1.00 $1.16
2021-12-23 $0.84 $1.00 $1.15
2021-12-27 $0.83 $0.99 $1.14
2021-12-28 $0.83 $0.98 $1.13
2021-12-29 $0.82 $0.97 $1.13
2021-12-30 $0.81 $0.97 $1.12
2021-12-31 $0.81 $0.96 $1.11
2022-01-03 $0.80 $0.95 $1.10
2022-01-04 $0.79 $0.94 $1.10
2022-01-05 $0.78 $0.94 $1.09
2022-01-06 $0.78 $0.93 $1.08
2022-01-07 $0.77 $0.92 $1.07
2022-01-10 $0.76 $0.91 $1.07
2022-01-11 $0.75 $0.91 $1.06
2022-01-12 $0.75 $0.90 $1.05
2022-01-13 $0.74 $0.89 $1.04
2022-01-14 $0.73 $0.88 $1.04
2022-01-17 $0.72 $0.88 $1.03
2022-01-18 $0.72 $0.87 $1.02
2022-01-19 $0.71 $0.86 $1.02
2022-01-20 $0.70 $0.85 $1.01

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase II clinical trials for the treatment of ischemic stroke and inflammatory bowel disease (IBD); and that has completed Phase I clinical trial for the treatment of acute myocardial infarction and hematopoietic... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT